Novel nasal spray therapy for dry eye shows promise

Oyster Point Pharma reported positive preliminary results from a phase 2b trial testing their novel drug for dry eye disease.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553